ELYPSE-7: a randomized placebo-controlled phase IIa trial with CYT107 exploring the restoration of CD4+ lymphocyte count in lymphopenic metastatic breast cancer patients

Ann Oncol. 2018 Feb 1;29(2):523. doi: 10.1093/annonc/mdx058.
No abstract available

Publication types

  • Published Erratum